Ocaratuzumab (Anti-CD20)

Ocaratuzumab (anti-CD20) is a Fc-engineered monoclonal antibody directed against human CD20 with potential antineoplastic activity. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC). MW: 145.38 kD.

• Supplier: Selleck Chemicals
• Product #: A2969
• Sku #: A2969-1mg